Compare Stocks

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AEMD Aethlon Medical	$1.50 -2.0%	$1.65	$1.35 ▼ $5.00	$4.01M	1.88	7,973 shs	442 shs
GBS GBS	$2.47 -3.9%	$4.05	$0.36 ▼ $2.89	$7.05M	1.32	955,325 shs	50,467 shs
NXGL NEXGEL	$2.29 +3.2%	$2.44	$1.40 ▼ $3.14	$13.76M	0.68	16,867 shs	6,570 shs
SINT Sintx Technologies	$0.04	$0.09	$0.02 ▼ $1.82	$880K	1.46	76.49 million shs	15.77 million shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AEMD Aethlon Medical	-1.76%	+6.22%	-14.11%	-16.50%	-61.92%
GBS GBS	-11.15%	-11.79%	-42.15%	+997.29%	-5.00%
NXGL NEXGEL	-1.93%	+3.63%	-15.68%	+2.93%	+47.42%
SINT Sintx Technologies	-5.43%	-8.50%	-25.76%	-87.69%	-97.68%

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AEMD Aethlon Medical	1.3641 of 5 stars	3.5	3.0	0.0	0.0	1.1	0.0	0.6
GBS GBS	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NXGL NEXGEL	0.508 of 5 stars	0.0	5.0	0.0	0.0	0.0	3.3	0.0
SINT Sintx Technologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AEMD Aethlon Medical	3.00	Buy	$10.00	565.34% Upside
GBS GBS	N/A	N/A	N/A	N/A
NXGL NEXGEL	N/A	N/A	N/A	N/A
SINT Sintx Technologies	2.00	Hold	N/A	N/A

Current Analyst Ratings

Latest AEMD, SINT, NXGL, and GBS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/4/2024	AEMD Aethlon Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$23.00 ➝ $10.00
2/5/2024	SINT Sintx Technologies	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AEMD Aethlon Medical	$570K	6.91	N/A	N/A	$6.56 per share	0.23
GBS GBS	$440K	83.59	N/A	N/A	$0.44 per share	5.61
NXGL NEXGEL	$4.09M	3.48	N/A	N/A	$0.90 per share	2.54
SINT Sintx Technologies	$2.63M	0.32	N/A	N/A	$1.65 per share	0.02

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AEMD Aethlon Medical	-$12.03M	-$4.99	N/A	N/A	N/A	N/A	-106.28%	-86.60%	6/26/2024 (Estimated)
GBS GBS	-$8.31M	-$0.56	N/A	N/A	N/A	N/A	-85.64%	-54.42%	N/A
NXGL NEXGEL	-$3.16M	-$0.56	N/A	∞	N/A	-77.19%	-49.49%	-30.50%	5/20/2024 (Estimated)
SINT Sintx Technologies	-$8.26M	-$3.42	N/A	∞	N/A	-314.39%	-67.12%	-45.49%	5/20/2024 (Estimated)

Latest AEMD, SINT, NXGL, and GBS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/1/2024	Q4 2023	NXGL NEXGEL	N/A	-$0.19	-$0.19	-$0.19	N/A	$1.08 million
3/27/2024	Q4 2023	SINT Sintx Technologies	N/A	-$0.09	-$0.09	-$0.09	N/A	$0.90 million
2/14/2024	Q3 2024	AEMD Aethlon Medical	-$1.23	-$1.37	-$0.14	-$1.37	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AEMD Aethlon Medical	N/A	N/A	N/A	N/A	N/A
GBS GBS	N/A	N/A	N/A	N/A	N/A
NXGL NEXGEL	N/A	N/A	N/A	N/A	N/A
SINT Sintx Technologies	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AEMD Aethlon Medical	N/A	3.93	3.93
GBS GBS	N/A	2.33	2.33
NXGL NEXGEL	0.10	1.98	1.46
SINT Sintx Technologies	N/A	1.90	1.60

Ownership

Institutional Ownership

Company	Institutional Ownership
AEMD Aethlon Medical	1.99%
GBS GBS	2.79%
NXGL NEXGEL	2.21%
SINT Sintx Technologies	18.38%

Insider Ownership

Company	Insider Ownership
AEMD Aethlon Medical	4.00%
GBS GBS	0.27%
NXGL NEXGEL	27.15%
SINT Sintx Technologies	1.00%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AEMD Aethlon Medical	15	2.62 million	2.52 million	Optionable
GBS GBS	7	14.89 million	14.85 million	Not Optionable
NXGL NEXGEL	12	6.23 million	4.54 million	Not Optionable
SINT Sintx Technologies	41	22.68 million	22.45 million	Not Optionable

AEMD, SINT, NXGL, and GBS Headlines

Source	Headline
	Why SINTX Technologies Stock Is Getting Hammered msn.com - April 3 at 2:48 PM
	SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock globenewswire.com - April 3 at 9:00 AM
	Why SINTX Technologies Stock Hit A New All-Time Low Today msn.com - April 1 at 3:51 PM
	DDC Appoints Vice President to Drive Operational Excellence itnewsonline.com - March 30 at 6:23 PM
	SINTX Technologies Announces Proposed Public Offering of Common Stock globenewswire.com - March 29 at 4:00 PM
	SINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023 investorplace.com - March 28 at 7:02 AM
	Sintx Technologies Prices Public Offering Of $1.3 Mln Of Shares markets.businessinsider.com - March 25 at 1:22 PM
	Why SINTX Technologies Stock Is Down 50% msn.com - March 25 at 1:22 PM
	Why Is Sintx Technologies (SINT) Stock Down 31% Today? investorplace.com - March 25 at 9:05 AM
	SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock globenewswire.com - March 25 at 9:00 AM
	US Stocks Edge Lower; FedEx Posts Upbeat Earnings msn.com - March 23 at 3:15 AM
	Why SINTX Technologies Is Trading Higher Today aol.com - March 22 at 10:14 PM
	Gold Moves Lower; Lululemon Shares Plummet msn.com - March 22 at 5:14 PM
	Dow Dips 200 Points; Nike Shares Fall After Q3 Results markets.businessinsider.com - March 22 at 5:14 PM
	SINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34% markets.businessinsider.com - March 22 at 5:14 PM
	Why SINTX Technologies Stock Is Nosediving msn.com - March 22 at 5:14 PM
	SINTX Technologies Announces Proposed Public Offering of Common Stock globenewswire.com - March 22 at 8:30 AM
	Sintx Technologies (SINT) Price Target Increased by 42.86% to 10.20 msn.com - February 24 at 2:14 PM
	Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI) benzinga.com - February 23 at 7:50 AM
	SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET finance.yahoo.com - February 21 at 3:58 PM
	SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET globenewswire.com - February 21 at 9:00 AM
	SINTX Technologies: Other Events cbonds.com - February 16 at 10:37 AM
	SINTX Technologies subsidiary enters R&D agreement with the U.S. Army DEVCOM ARL for ceramic additive manufacturing tctmagazine.com - February 7 at 10:57 AM
	Sintx Technologies just downgraded at Maxim, here's why realmoney.thestreet.com - February 5 at 5:59 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aethlon Medical

NASDAQ:AEMD

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.

GBS

NYSE:GBS

GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

NEXGEL

NASDAQ:NXGL

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Sintx Technologies

NASDAQ:SINT

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial